ReShape Lifesciences Inc
Medical Devices
Healthcare
RSLS
3.10 K shares
NASDAQ US
traded
14 Aug 2025
listed
no
open
3.06
52 week high
16.24
high
4.65
52 week low
0.00
low
2.80
growth
-62.31 %
previous Close
3.20
P/E ratio
-2
market cap
5.77 M
div yield
0
usd
Mar 2025
qoq
revenue
1.11 M
-51.44 %
net incoming
1.47 M
193.23 %
eps
-2.41 %
22.36 %
eps surprise
-3346.29 %
net profit margin
132.43 %
201.00 %
operating incoming
-2.21 M
-25.27 %
net change in cash
1.82 M
687.74 %
cash on hand
2.52 M
238.49 %
cost of revenue
432 K
-49.36 %
top top